Suppr超能文献

对感染性危重症患者使用扑热息痛治疗:一项回顾性观察研究。

Paracetamol therapy for septic critically ill patients: a retrospective observational study.

机构信息

Department of Intensive Care Medicine, Austin Hospital, Melbourne, VIC, Australia.

出版信息

Crit Care Resusc. 2011 Sep;13(3):181-6.

Abstract

BACKGROUND

There is little information on the use of paracetamol for septic critically ill patients. We hypothesised that paracetamol use is common in such patients, but its administration is not predictably related to body temperature.

OBJECTIVE

To study the epidemiology and associations of paracetamol use in a cohort of septic critically ill patients.

DESIGN

Retrospective observational study.

PATIENTS AND SETTING

Cohort of 106 patients admitted with a sepsis-related diagnostic code to the intensive care unit of a tertiary hospital, 14 December 2009 - 8 August 2010.

METHODS

Using the ICU database, we identified all patients admitted with sepsis during the study period. We audited their electronic medical records to identify paracetamol administration and body temperature. The paracetamol administered and tympanic temperature at 00:00, 06:00, 12:00 and 18:00 hours for the first 7 days of admission were recorded. The reason for paracetamol administration was not documented.

RESULTS

73/106 (69%) patients received paracetamol at least once; 10% of all patients and 23% of postoperative patients had paracetamol for every temperature measurement. The median length of stay was 3 days and the mean total ICU paracetamol dose per patient was 6.4 g. Overall, 44% of patients received paracetamol for their peak temperature (56% in the fever group v 37% in the non-fever group; P = 0.07). Only 36/106 patients had a fever and 88% in the fever group had paracetamol at least once in the first 7 days, compared with 60% in the non-fever group (P=0.004). After adjustment for key variables, patients with fever were more likely to receive paracetamol (odds ratio, 6.8 [95% CI, 1.9- 24.7]; P=0.004). Patients with fever were more likely to die in ICU than patients without fever (P<0.001), although those who died in ICU did not receive more paracetamol.

CONCLUSIONS

Paracetamol administration is common among septic critically ill patients with or without fever, and more likely to occur when fever is present. However, paracetamol is not predictably given for the highest temperature in febrile patients. Future investigations are needed to understand under what circumstances and why paracetamol is given or not given to febrile or afebrile septic ICU patients.

摘要

背景

关于败血症危重症患者使用扑热息痛的信息很少。我们假设扑热息痛的使用在这类患者中很常见,但它的使用与体温并无明显关系。

目的

研究败血症危重症患者中扑热息痛的使用情况及相关因素。

设计

回顾性观察性研究。

患者和设置

2009 年 12 月 14 日至 2010 年 8 月 8 日,三级医院 ICU 中因败血症相关诊断代码而入院的 106 例患者队列。

方法

使用 ICU 数据库,我们确定了研究期间所有因败血症入院的患者。我们审核了他们的电子病历,以确定扑热息痛的使用情况和体温。记录了入院第 1 天的 00:00、06:00、12:00 和 18:00 点的扑热息痛用量和鼓膜温度。扑热息痛使用的原因未记录。

结果

106 例患者中 73 例(69%)至少使用过一次扑热息痛;10%的所有患者和 23%的术后患者每次测量体温时都使用扑热息痛。中位住院时间为 3 天,每位患者的 ICU 扑热息痛总剂量平均为 6.4g。总体而言,44%的患者在体温峰值时使用了扑热息痛(发热组为 56%,非发热组为 37%;P=0.07)。只有 36/106 例患者发热,发热组 88%的患者在第 1 天至少使用了一次扑热息痛,而非发热组为 60%(P=0.004)。调整关键变量后,发热患者更有可能使用扑热息痛(比值比,6.8[95%CI,1.9-24.7];P=0.004)。发热患者 ICU 死亡率高于无发热患者(P<0.001),但 ICU 死亡患者并未使用更多扑热息痛。

结论

有或无发热的败血症危重症患者中扑热息痛的使用很常见,且发热时更有可能使用。然而,在发热患者中,扑热息痛并不一定在体温最高时使用。需要进一步研究以了解在何种情况下以及为何发热或不发热的败血症 ICU 患者使用或不使用扑热息痛。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验